Upgrades & Downgrades

Format: 2015-08-01
Format: 06:03

Change in Ratings

Bearish
AmerisourceBergen downgraded at Mizuho
Jan 04, 2013 | 6:55 AM EST

ABC was downgraded from Buy to Netural, Robert Baird said. Valuation call, based on a $45 price target.

 

Bearish
Abbott Laboratories downgraded at Deutsche
Jan 04, 2013 | 7:58 AM EST

ABT was downgraded from Buy to Hold, Deutsche Bank said. Valuation call, based on a $33 price target. 

Aruba Networks upgraded at Stifel
Jan 04, 2013 | 8:02 AM EST

ARUN was upgraded from Hold to Buy, Stifel Nicolaus said. $27 price target. Growth could re-accelerate in 2013. 

 

Bullish
Avon Products upgraded at BofA/Merrill
Jan 04, 2013 | 8:26 AM EST

AVP was upgraded from Neutral to Buy, Bank of America/Merrill Lynch said. $20 price target. Company is in the midst of a turnaround. 

Bearish
The Bank of New York Mellon downgraded at Citigroup
Jan 04, 2013 | 8:14 AM EST

Shares of BK downgraded to Neutral from Buy, Citi said. Valuation call.

Bearish
BancorpSouth downgraded at KBW
Jan 04, 2013 | 8:20 AM EST

BXS was downgraded from Market Perform to Underperform, Keefe, Bruyette & Woods said. Valuation call, based on a $12 price target. 

Bullish
Cardinal Health upgraded at Mizuho
Jan 04, 2013 | 6:53 AM EST

CAH was upgraded from Neutral to Buy, Mizuho said. $46 price target. Company will likely renew two major contracts in 2013.

 

Bullish
Continental Resources rated new Buy at Deutsche
Jan 04, 2013 | 7:50 AM EST

Coverage of CLR was started with a Buy rating, Deutsche Bank said. $94 price target. Solid Bakken position can continue to drive growth. 

Cepheid downgraded at Piper
Jan 04, 2013 | 7:43 AM EST

CPHD was downgraded from Overweight to Neutral, Piper Jaffray said. $34 price target. See further downside potential to near-term results. 

Endo Pharmaceuticals downgraded at Piper
Jan 04, 2013 | 7:48 AM EST

ENDP was downgraded from Overweight to Neutral, Piper Jaffray said. Opana ER is facing generic competition. $28 price target. 

Bullish
Esco Technologies upgraded at Baird
Jan 04, 2013 | 6:50 AM EST

ESE was upgraded from Neutral to Outperform, Robert Baird said. $52 price target. Company should see higher orders in the near term. 

Update
Edwards Lifesciences rated new Market Perform at JMP
Jan 04, 2013 | 7:46 AM EST

EW was initiated with a Market Perform rating, JMP Securities said. Company trades at a premium to its peers, but has limited upside earnings potential. 

East West Bancorp upgraded at Sterne Agee
Jan 04, 2013 | 8:12 AM EST

Shares of EWBC upgraded to Buy from Neutral, Sterne Agee said. $26 price target. Earnings power from expense management. 

Bearish
FactSet Research Systems initiated at Goldman Sachs
Jan 04, 2013 | 8:10 AM EST

Shares of FDS rated new Sell, Goldman Sachs said. $79 price target. Slowing growth and emerging competition.

Bearish
Freescale downgraded at JP Morgan
Jan 04, 2013 | 8:19 AM EST

FSL was downgraded to Neutral, JP Morgan said. Company could see lower demand and lacks near-term catalysts. 

Illumina downgraded at Wedbush
Jan 04, 2013 | 8:25 AM EST

Shares of ILMN downgraded to Neutral from Outperform, Wedbush said. $52 price target. Diminished risk/reward due to gain in share price.

Illumina upgraded at Piper
Jan 04, 2013 | 7:44 AM EST

ILMN was upgraded from Neutral to Overweight, Piper Jaffray said. $61 price target. Company can continue to gain market share in next-generation sequencing. 

IPG Photonics downgraded at Stifel
Jan 04, 2013 | 8:32 AM EST

IPGP was downgraded from Buy to Hold, Stifel Nicolaus said. Valuation call. 

 

Bullish
Johnson & Johnson upgraded at Deutsche
Jan 04, 2013 | 7:57 AM EST

JNJ was upgraded to Buy, Deutsche Bank said. $82 price target. Company has a diversified business and deserves to trade at a premium valuation.

Lululemon downgraded at Credit Suisse
Jan 04, 2013 | 8:15 AM EST

LULU was downgraded from Outperform to Neutral, Credit Suisse said. $80 price target. Comp sales growth is slowing, which could weigh on margins. 

Bullish
Mattel upgraded at Needham
Jan 04, 2013 | 6:48 AM EST

MAT was upgraded from Hold to Buy, Needham said. Company likely gained market share during the holiday season. 

 

Microsoft downgraded at Argus
Jan 04, 2013 | 8:29 AM EST

MSFT was downgraded from Buy to Hold, Argus said. Windows 8 is not selling well, which may note a secular shift away from the operating system.

 

Shutterfly upgraded at Topeka
Jan 04, 2013 | 7:59 AM EST

SFLY was upgraded from Hold to Buy, Topeka said. $40 price target. Have increased confidence in management's ability to deal with increased competition. 

Texas Roadhouse upgraded at Deutsche
Jan 04, 2013 | 7:53 AM EST

TXRH was upgraded from Hold to Buy, Deutsche Bank said. $20 price target. Company can continue execute in a difficult environment.  

Bullish
Textron upgraded at Credit Suisse
Jan 04, 2013 | 8:17 AM EST

TXT was upgraded from Neutral to Outperform, Credit Suisse said. $30 price target. Market expectations have come down to achievable levels. 

Bullish
Under Armour upgraded at Credit Suisse
Jan 04, 2013 | 8:14 AM EST

UA was upgraded from Neutral to Outperform, Credit Suisse said. $59 price target. Estimates also boosted, as the company is leveraged to secular growth trends. 

Urban Outfitters upgraded at Credit Suisse
Jan 04, 2013 | 8:16 AM EST

URBN was upgraded from Neutral to Outperform, Credit Suisse said. $48 price target. Estimates also boosted, given better industry trends. 

Bullish
US Bancorp upgraded at Deutsche
Jan 04, 2013 | 7:55 AM EST

USB was upgraded from Hold to Buy, Deutsche Bank said. $38 price target. Company is best leveraged to reform in the GSE/mortgage space. 

Stock Comments / EPS Changes

Bullish
Dow Chemical numbers raised at Jefferies
Jan 04, 2013 | 8:04 AM EST

Shares of DOW now seen reaching $34, Jefferies said. Estimates also raised on falling feedstock prices. Hold rating.

Bullish
Eastman Chemical numbers raised at Jefferies
Jan 04, 2013 | 8:07 AM EST

Shares of EMN now seen reaching $71, Jefferies said. Estimates also raised on lower priced feedstocks. Hold rating.

Endo Health Solutions numbers lowered at Oppenheimer
Jan 04, 2013 | 8:00 AM EST

Shares of ENDP now seen reaching $32, Oppenheimer said. Estimates also lowered generic competition. Outperform rating.

Endo Health Solutions numbers lowered at UBS
Jan 04, 2013 | 8:19 AM EST

Shares of ENDP now seen reaching $40, UBS said. Estimates also lowered on 2013 guidance. Buy rating.

Bearish
Family Dollar numbers cut at Credit Suisse
Jan 04, 2013 | 8:22 AM EST

Shares of FDO now seen reaching $65, according to Credit Suisse. Estimates also reduced, given the company's new guidance. Outperform rating. 

Bearish
Kohl's estimates, target reduced at Nomura
Jan 04, 2013 | 8:23 AM EST

KSS estimates were cut through 2013, Nomura said. Comp sales will likely fall with inventory levels. Neutral rating and new $41 price target. 

Bearish
Limited Brands numbers lowered at Nomura
Jan 04, 2013 | 8:24 AM EST

Shares of LTD now seen reaching $52, according to Nomura. Estimates also cut, as the company is seeing lower sales. Buy rating. 

Bullish
PPG number raised at UBS
Jan 04, 2013 | 8:17 AM EST

Shares of PPG now seen reaching $136, UBS said. Estimates also raised on Deco paints deal. Neutral rating.

Bullish
Valero target raised at Oppeneheimer
Jan 04, 2013 | 8:02 AM EST

Shares of VLO now seen reaching $40, Oppenheimer said. New projects improve outlook. Outperform rating.

Economics

Update
Nonfarm Payrolls
Jan 04, 2013 | 6:19 AM EST

8:30am: Nonfarm Payrolls, Dec., est. 153k (prior 146k)

Update
Unemployment Rate
Jan 04, 2013 | 6:20 AM EST

8:30am: Unemployment Rate, Dec., est. 7.7% (prior 7.7%)

Update
Factory Orders
Jan 04, 2013 | 6:20 AM EST

10am: Factory Orders, Nov., est. 0.4% (prior 0.8%)

Update
ISM non-Mfg.
Jan 04, 2013 | 6:23 AM EST

10am: ISM Non-Manf. Composite, Dec., est. 54.0 (prior 54.7)

Columnist Conversations

$51 billion - How much Uber is valued at in its last financing round. The unicorns keep growing. Back in the ...
....put protection is cheap! Seems every time we come down to this 12 or 11 level in VIX there is a whack, an...
Chevron (CVX) and the weak weekly chart, or is it?    Why would anyone want to buy a stock that is...
Care to comment on my prior post?

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.